BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27704169)

  • 21. Nuclear factor κB down-regulates human UDP-glucuronosyltransferase 1A1: a novel mechanism involved in inflammation-associated hyperbilirubinaemia.
    Shiu TY; Huang TY; Huang SM; Shih YL; Chu HC; Chang WK; Hsieh TY
    Biochem J; 2013 Feb; 449(3):761-70. PubMed ID: 23130636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
    Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.
    Long J; Zhang S; Fang X; Luo Y; Liu J
    Acta Paediatr; 2011 Jul; 100(7):966-71. PubMed ID: 21272068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.
    Kringen MK; Piehler AP; Grimholt RM; Opdal MS; Haug KB; Urdal P
    PLoS One; 2014; 9(2):e90248. PubMed ID: 24587300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations.
    Zhang A; Xing Q; Qin S; Du J; Wang L; Yu L; Li X; Xu L; Xu M; Feng G; He L
    Pharmacogenomics J; 2007 Oct; 7(5):333-8. PubMed ID: 17060921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.
    Toffoli G; Cecchin E; Corona G; Russo A; Buonadonna A; D'Andrea M; Pasetto LM; Pessa S; Errante D; De Pangher V; Giusto M; Medici M; Gaion F; Sandri P; Galligioni E; Bonura S; Boccalon M; Biason P; Frustaci S
    J Clin Oncol; 2006 Jul; 24(19):3061-8. PubMed ID: 16809730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.
    Yang H; Wang Q; Zheng L; Zheng XB; Lin M; Zhan XF; Yang LY
    Pediatr Neonatol; 2016 Aug; 57(4):310-7. PubMed ID: 26727668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.
    Maruo Y; Morioka Y; Fujito H; Nakahara S; Yanagi T; Matsui K; Mori A; Sato H; Tukey RH; Takeuchi Y
    J Pediatr; 2014 Jul; 165(1):36-41.e1. PubMed ID: 24650397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
    Xu CF; Reck BH; Xue Z; Huang L; Baker KL; Chen M; Chen EP; Ellens HE; Mooser VE; Cardon LR; Spraggs CF; Pandite L
    Br J Cancer; 2010 Apr; 102(9):1371-7. PubMed ID: 20389299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma.
    Liu CY; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
    Cancer; 2008 May; 112(9):1932-40. PubMed ID: 18300238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of UGT1A1(*)28 and (*)6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients.
    Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Chamnanphon M; Puangpetch A; Wongwaisayawan S; Sukasem C
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):90-94. PubMed ID: 26830078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
    Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
    Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)].
    Wang X; Liu Y; Huang JX; Lu P; Ba Y; Wu L; Bai YX; Zhang S; Feng JF; Cheng Y; Li J; Wen L; Yuan XL; Ma CW; Hu CH; Fan QX; Xu BH; Huang J
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1177-1182. PubMed ID: 34794220
    [No Abstract]   [Full Text] [Related]  

  • 34. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.
    Maruo Y; Nakahara S; Yanagi T; Nomura A; Mimura Y; Matsui K; Sato H; Takeuchi Y
    J Gastroenterol Hepatol; 2016 Feb; 31(2):403-8. PubMed ID: 26250421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.
    Lin R; Wang X; Wang Y; Zhang F; Wang Y; Fu W; Yu T; Li S; Xiong M; Huang W; Jin L
    Hum Mutat; 2009 Apr; 30(4):609-15. PubMed ID: 19243019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.
    Zhang X; Meng X; Wang Y; Yan W; Yang J
    Biochem Genet; 2012 Dec; 50(11-12):967-77. PubMed ID: 22983686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang.
    Chen S; Hua L; Feng C; Mo Q; Wei M; Shen Y; Lin Z; Li G; Xu J; Guo C; Huang H
    BMC Gastroenterol; 2020 Apr; 20(1):96. PubMed ID: 32264830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients.
    Gao J; Zhou J; Li Y; Lu M; Jia R; Shen L
    Med Oncol; 2013; 30(3):604. PubMed ID: 23686699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.
    Fujiwara R; Nguyen N; Chen S; Tukey RH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5024-9. PubMed ID: 20194756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
    Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
    J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.